Please login to the form below

Not currently logged in
Email:
Password:

Tonix names chief medical officer

Gregory Sullivan is experience academic in psychiatry

The clinical-stage specialty pharma company Tonix Pharmaceuticals has named Dr Gregory Sullivan as its first chief medical officer.

Dr Sullivan, an experienced psychiatrist and researcher, will oversee medical aspects of the New York headquartered company's clinical research and development programme, which is focused on developing treatments for diseases of the central nervous system.

It is the second senior clinical appointment that Tonix has made this year following the hire of Dr Donald Kellerman as senior VP, clinical development and regulatory affairs.

Tonix is bulking up its research team as it anticipates the first trial involving lead candidate TNX-102 SL in fibromyalgia. The drug is also in a more advanced stage of research for post-traumatic stress disorder (PTSD).

Dr Sullivan has enjoyed an extensive clinical career including experience as an assistant Professor of Psychiatry in the Department of Psychiatry at Columbia University Medical Center, a research scientist at the New York State Psychiatric Institute (NYSPI), and as a practicing psychiatrist.

His expertise includes PTSD and has been involved in several studies into the condition. He has also served on the scientific advisory board at Tonix since 2010.

"It is my hope that my medical expertise and scientific background will contribute to the successful development of this promising pipeline of novel therapeutic candidates to bring much needed treatment options to patients suffering with these challenging conditions,” said Dr Sullivan.

4th June 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics